AMBER unveils new bone repair technology AMBER.
And which brought collectively several AMBER's industry companions. The patented bone fix technology originated by a team of AMBER Experts within the Tissue Engineering Study Group in the Royal College of Surgeons in Ireland led by Professor Fergal O'Brien, Deputy Director of AMBER. It consists of hydroxyapatite and collagen, components indigenous to bone, formed right into a 3D porous 'scaffold' which acts as a bone graft alternative. Speaking at the event, Damien English T.D., Minister for Skills, Research and Innovation said, ‘It has been an extremely successful first 12 months for AMBER, this exciting technology is usually another example that presents that Irish research reaches the industry leading of material science worldwide.Bauer is the director of UC Davis’ Good Production Practice laboratory in Sacramento. Upon its completion, UC Davis will be one of the few universities with a large GMP facility where researchers will work in an ultra-clean environment to derive cellular products that, after qualification and extensive testing, will be used to treat patients. The California Institute for Regenerative Medication has recommended financing because of this new facility to greatly help bring an array of stem cell therapy cures to sufferers throughout California.